Viemed Healthcare (VMD) Stock Forecast & Price Target

$7.11
+0.04 (+0.57%)
(As of 05/17/2024 ET)

Viemed Healthcare Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Strong Buy
Based on 1 Analyst Ratings

Analysts' Consensus Price Target

N/A

TypeCurrent Forecast
5/20/23 to 5/19/24
1 Month Ago
4/20/23 to 4/19/24
3 Months Ago
2/19/23 to 2/19/24
1 Year Ago
5/20/22 to 5/20/23
Consensus Rating
Strong Buy
N/AN/AN/A
Strong Buy
1 Strong Buy rating(s)
N/A N/A N/A
Buy
0 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price TargetN/AN/AN/AN/A
Predicted UpsideN/AN/AN/AN/A
Get Viemed Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter.

VMD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

VMD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Viemed Healthcare Stock vs. The Competition

TypeViemed HealthcareMedical CompaniesS&P 500
Consensus Rating Score
4.00
2.69
2.49
Consensus RatingStrong BuyModerate BuyHold
Predicted Upside849.10% Upside7.85% Upside
News Sentiment RatingVery Positive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/7/2024Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. O'neil
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:04 AM ET.

VMD Price Target - Frequently Asked Questions

What is Viemed Healthcare's consensus rating?

According to the issued ratings of 1 analysts in the last year, the consensus rating for Viemed Healthcare stock is Strong Buy based on the current 1 strong buy rating for VMDthe . Learn more on VMD's analyst rating history.

Do Wall Street analysts like Viemed Healthcare more than its competitors?

Analysts like Viemed Healthcare more than other Medical companies. The consensus rating for Viemed Healthcare is Strong Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how VMD compares to other companies.

Is Viemed Healthcare being upgraded by Wall Street analysts?

Over the previous 90 days, Viemed Healthcare's stock had 1 upgrade by analysts.

What analysts cover Viemed Healthcare?

Viemed Healthcare has been rated by Lake Street Capital in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:VMD) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners